Literature DB >> 3458320

Absorbed doses from intraoral radiography with special emphasis on collimator dimensions.

B Stenström, C O Henrikson, B Holm, S Richter.   

Abstract

Thermoluminescence dosimeters were used in a phantom head and on patients to measure the absorbed dose to organs of special interest from full surveys with intraoral films (20 exposures) and single bitewing exposures. Two x-ray machines were used, operating at 65 kVp. The apertures of the circular tube collimators had diameters of 55 mm and 48 mm. Rectangular (35 mm X 44 mm) tube collimators were also used. The distance from the x-ray focus to the open end of the collimators (FSD) was 0.20 and 0.35 m. Exposure values for Kodak Ultra-Speed film (speed group D) were used. The maximum skin dose measured from the full surveys decreased by 25 per cent on changing from the circular to the rectangular apertures. Using 0.35 m FSD and rectangular collimator the maximum skin dose was 13 mGy. The absorbed doses to the salivary glands and the thyroid gland were significantly reduced on changing from circular to rectangular apertures. The doses in the central part of the parotid and the thyroid glands were then 0.5 and 0.12 mGy, respectively, from a full survey with 20 intraoral films. With a leaded shield the thyroid dose was reduced to 0.05 mGy. All dose values could be further reduced by 40 per cent by using Kodak Ektaspeed film (speed group E).

Entities:  

Mesh:

Year:  1986        PMID: 3458320

Source DB:  PubMed          Journal:  Swed Dent J        ISSN: 0347-9994


  2 in total

1.  Diagnostic Dental Radiation Risk during Pregnancy: Awareness among General Dentists in Tabriz.

Authors:  Tahmineh Razi; Leila Bazvand; Morteza Ghojazadeh
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2011-06-14

2.  Evidence on radiation dose reduction using rectangular collimation: a systematic review.

Authors:  Avdeesh Shetty; Fabiana T Almeida; Seema Ganatra; Anthea Senior; Camila Pacheco-Pereira
Journal:  Int Dent J       Date:  2018-06-29       Impact factor: 2.607

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.